Medipal Secures KRW 5 Billion in Series A
Medipal, a South Korea-based aftercare SaaS solution company, has secured KRW 5 billion in Series A funding, bringing its total funding to KRW 7 billion.
Medipal, a South Korea-based aftercare SaaS solution company, has secured KRW 5 billion in Series A funding, bringing its total funding to KRW 7 billion.
SaaS Investors
Bass Investment and Insight Equity Partners, existing investors, participated in this round, with KT Investment joining as a new investor.
Medipal Use of Funds
With this investment, The company will help first and second-tier clinics become central players in local healthcare and further enhance the continuity of patient care.
About Medipal
Medipal is a digital health startup that operates the patient re-visit management solution AfterDoc for clinics and medical practices. Medipal's AfterDoc platform, launched in 2021, helps medical clinics with post-appointment tasks, patient health monitoring, daily health consulting, and appointment management.
Funding Details
Company: Medipal, Inc.
Raised: KRW 5 Billion
Round: Series A
Funding Month: November 2023
Lead Investors:
Additional Investors: Bass Investment, Insight Equity Partners, KT Investment
Company Website: https://medipal.co.kr/
Software Category: Aftercare SaaS Solution
